BSEAchyut Healthcare Ltd· Pharmaceuticals & BiotechnologyHighPositive
Announced Tue, 23 Sept, 2025 · 15:16 IST

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Akshit M Raycha HUF

Promoter Stake BuyOwnership Changes View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+4.7%Reaction day
₹5.94
prior close
₹6.22
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.3%+5.0% vs market
Pharmaceuticals peers, median of 154sector-0.4%+5.1% vs sector

On the reaction day the stock moved 5.0 pts more than Nifty Microcap 250 and 5.1 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
+0.0
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+4.7-0.3+5.0-0.4+5.1
Next day
+9.6-0.6+10.2-0.7+10.3
2d
+7.9-1.7+9.6-1.4+9.3
3d
+5.9-3.8+9.7-3.4+9.2
4d
+3.9-4.6+8.5-3.4+7.3
5d
—-5.0—-3.3—
1w
—-2.4—-2.2—
15d
—-3.0—-3.9—
1m
—-1.4—-2.9—
2m
-6.2-4.9-1.4-6.3+0.1
3m
-1.5-5.9+4.4-6.7+5.2
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 154Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Akshit M Raycha HUF, part of the promoter/promoter group of Achyut Healthcare Ltd, acquired 63,000 equity shares (0.03% of total share capital) via the open market on September 22, 2025. Prior to the acquisition, the HUF held 28,69,020 shares (1.22%), which has now increased to 29,32,020 shares (1.24%). The shares were acquired outright with no encumbrance created. Equity share capital remains Rs. 23,55,57,000 comprising 23,55,57,000 equity shares of Re. 1 each.

Likely market impact

This is a small open-market purchase by a promoter group entity, signaling modest insider confidence but with negligible impact on overall shareholding or stock price given the minimal size (0.03% increase).